Author(s): Slobodchikova I; Sivakumar R; Rahman MS; Vuckovic D;

Routine mycotoxin biomonitoring methods do not include many mycotoxin phase I and phase II metabolites, which may significantly underestimate mycotoxin exposure especially for heavily metabolized mycotoxins. Additional research efforts are also needed to measure metabolites in vivo after exposure and to establish which mycotoxin metabolites should be prio ...

Article GUID: 31344861